Article
Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Liver international : official journal of the International Association for the Study of the Liver - 1 Mar 2016
Péron Jean Marie, Abravanel Florence, Guillaume Maeva, Gérolami René, Nana Jean, Anty Rodolphe, Pariente Alexandre, Renou Christophe, Bureau Christophe, Robic Marie-Angèle, Alric Laurent, Vinel Jean Pierre, Izopet Jacques, Kamar Nassim
Abstract excerpt
BACKGROUND & AIMS: Hepatitis E virus (HEV) genotypes 3 and 4 cause sporadic cases of infection in developed countries. Being elderly and having an underlying liver disease are the main risk factors for death in this population. Chronic infection has been described in immunocompromised patients. Ribavirin is now the antiviral treatment of choice in solid-organ-transplant recipients with chronic HEV infection. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.